Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

Cancer Chemotherapy and Pharmacology

Volumn 67, Issue 3, 2011, Pages 519-525

  Goldstein, David ^a   Gainford, M Corona ^b   Brown, Chris ^b   Tebbutt, Niall ^c   Ackland, Stephen P ^d   Van Hazel, Guy ^e   Jefford, Michael ^f,g   Abdi, Ehtesham ^h   Selva Nayagam, Sid ⁱ   Gebski, Val ^b   Miller, Danielle ^b   Shannon, Jenny ^j  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c AUSTIN HEALTH   (Australia)

^d CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^e SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^f PETER MACCALLUM CANCER CENTRE   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h Tweed Cancer Care Centre   (Australia)

ⁱ ROYAL ADELAIDE HOSPITAL   (Australia)

^j Nepean Cancer Care Centre   (Australia)

more..

Author keywords

Biliary tract cancer; Cancer antigen 19 9; Cisplatin; Fixed dose rate gemcitabine; Phase II trial

Indexed keywords

CANCER ANTIGEN CA 19-9; CISPLATIN; GEMCITABINE; TUMOR ANTIGEN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CA 19-9 ANTIGEN; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; BILE DUCT CARCINOMA; BLEEDING; CHEMOTHERAPY INDUCED EMESIS; DIARRHEA; DOSE RESPONSE; DRUG ACTIVITY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HEART INFARCTION; HUMAN; INFECTION; INOPERABLE CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; STOMATITIS; SURVIVAL TIME; THROMBOCYTOPENIA; BILIARY TRACT TUMOR; CLINICAL TRIAL; DISEASE FREE SURVIVAL; METABOLISM; MIDDLE AGED; PATHOLOGY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILIARY TRACT NEOPLASMS; CA-19-9 ANTIGEN; CISPLATIN; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; SURVIVAL; TREATMENT OUTCOME;

EID: 79953778021     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-010-1351-8     Document Type: Article

References (29)

1. RT Greenlee MB Hill-Harmon T Murray, et al. 2001 Cancer statistics, 2001 CA Cancer J Clin 51 15 36 1:STN:280:DC%2BD3MrjtFGisg%3D%3D 10.3322/canjclin.51. 1.15 11577478 (Pubitemid 32166444)
2. T Patel 2002 Worldwide trends in mortality from biliary tract malignancies BMC Cancer 2 10 10.1186/1471-2407-2-10 11991810 (Pubitemid 38851311)
3. F Eckel RM Schmid 2007 Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials Br J Cancer 96 896 902 1:CAS:528: DC%2BD2sXjt1SrsLw%3D 10.1038/sj.bjc.6603648 17325704 (Pubitemid 46452283)
4. LM Pasetto MR D'Andrea C Falci, et al. 2007 Gemcitabine in advanced biliary tract cancers Crit Rev Oncol Haematol 61 230 242 10.1016/j.critrevonc. 2006.04.006 (Pubitemid 46343607)
5. JL Abbruzzese R Grunewald EA Weeks, et al. 1991 A phase I clinical, plasma and pharmacology study of gemcitabine J Clin Oncol 9 491 498 1:STN:280:DyaK3M7lsVymtg%3D%3D 1999720
6. M Tempero W Plunkett VR van Haperen, et al. 2003 Randomised phase II comparison of fixed dose-intense gemcitabine: thirty minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma J Clin Oncol 21 3402 3408 1:CAS:528:DC%2BD2cXpsVKjtLs%3D 10.1200/JCO.2003.09.140 12885837 (Pubitemid 46594072)
7. E Poplin Y Feng J Berlin, et al. 2009 Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the eastern cooperative oncology J Clin Oncol 27 3778 3785 1:CAS:528:DC%2BD1MXhtFaitr3L 10.1200/JCO.2008.20.9007 19581537
8. GJ Peters AM Bergman VW Ruiz van Haperen, et al. 1995 Interaction between cisplatin and gemcitabine in vitro and in vivo Semin Oncol 22 72 79 1:CAS:528:DyaK2MXpsFGnurY%3D 7481849
9. CJ Van Moorsel HM Pinedo G Veerman, et al. 1999 Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small cell lung cancer cell lines Br J Cancer 80 981 990 10.1038/sj.bjc.6690452 10362105 (Pubitemid 29233918)
10. Valle JW, Wasan HS, Palmer DD et al (2009) Gemcitabine with or without cisplatin in patients with advanced or metastatic biliary tract cancer: results of a multicenter, randomized phase III trial (the UK ABC-02 trial). J Clin Oncol 27:15s (abstract 4503)
11. A Ko E Dito B Schillinger, et al. 2006 Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas J Clin Oncol 24 379 385 1:CAS:528:DC%2BD28XhsFSku78%3D 10.1200/JCO.2005.01.8267 16344320 (Pubitemid 46630456)
12. P Therasse SG Arbuck EA Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 205 216 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10.1093/jnci/92.3.205 10655437 (Pubitemid 30099779)
13. GJ Rustin AE Nelstrop P McClean, et al. 1996 Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125 J Clin Oncol 14 1545 1551 1:CAS:528:DyaK28XjtFKisLY%3D 8622070 (Pubitemid 26134212)
14. JA Meyerhardt A Zhu K Stuart, et al. 2008 Phase II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer Dig Dis Sci 53 564 570 1:CAS:528:DC%2BD1cXhtFWksLY%3D 10.1007/s10620-007-9885-2 17597402 (Pubitemid 351170025)
15. J Lee TY Kim MA Lee, et al. 2008 Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas Cancer Chemother Pharmacol 61 47 52 1:CAS:528:DC%2BD2sXhtFSrtbbO 10.1007/s00280-007- 0444-5 17364190 (Pubitemid 47512625)
16. F Giuliani V Gebbia E Maiello, et al. 2006 Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicentre phase II study of the Gruppo Oncologica dell'Italia Meridionale Ann Oncol 17 vii73 vii77 10.1093/annonc/mdl956 16760299 (Pubitemid 43985185)
17. BK Park YJ Kim JY Park, et al. 2006 Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer J Gastronenterol Hepatol 21 993 1003
18. ST Kim JO Park J Lee, et al. 2006 A phase II study of gemcitabine and cisplatin in advanced biliary tract cancer Cancer 106 1339 1346 1:CAS:528:DC%2BD28XjtVCrsbo%3D 10.1002/cncr.21741 16475213 (Pubitemid 43363912)
19. S Thongprasert S Napapan C Charoentum, et al. 2005 Phase II study of gemcitabine and cisplatin as first line chemotherapy in inoperable biliary tract carcinoma Ann Oncol 16 279 281 1:STN:280:DC%2BD2M%2FjvFyhsw%3D%3D 10.1093/annonc/mdi046 15668284 (Pubitemid 40309310)
20. DC Doval JS Sekhon SK Gupta, et al. 2004 A phase II study of gemcitabine and cisplatin in chemotherapy naïve, unresectable gallbladder cancer Br J Cancer 90 1516 1520 1:CAS:528:DC%2BD2cXjtVWktL4%3D 10.1038/sj.bjc.6601736 15083178 (Pubitemid 38648231)
21. J Reyes-Vidal J Gallardo E Yanez, et al. 2003 Gemcitabine and cisplatin in the treatment of patients with unresectable or metastatic gallbladder cancer: results of the phase II GOCCHI study Proc Am Soc Clin 22 273 abstract 1095
22. GW Lee JH Kang HG Kim, et al. 2006 Combination chemotherapy with gemcitabine and cisplatin as first line treatment for immunohistochemically proven cholangiocarcinoma Am J Clin Oncol 29 127 131 1:CAS:528: DC%2BD28XktlSms74%3D 10.1097/01.coc.0000203742.22828.bb 16601429 (Pubitemid 44270949)
23. AH Ko J Hwang AP Venook, et al. 2005 Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed dose rate gemcitabine for advanced pancreatic cancer Br J Cancer 93 195 199 1:CAS:528:DC%2BD2MXmt1yhurs%3D 10.1038/sj.bjc.6602687 15999098 (Pubitemid 41133205)
24. J Harder O Kummer M Olschewski, et al. 2007 Prognostic relevance of Carbohydrate Antigen 19.9 levels in patients with advanced biliary tract cancer Cancer Epidemiol Biomarkers Prev 16 2097 2100 1:CAS:528:DC%2BD2sXhtFGjtb%2FL 10.1158/1055-9965.EPI-07-0155 17932358 (Pubitemid 47621186)
25. RP Riechelmann CA Townsley SN Chin, et al. 2007 Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer Cancer 110 1307 1312 1:CAS:528:DC%2BD2sXhtFCgtr%2FO 10.1002/cncr.22902 17628484 (Pubitemid 47435603)
26. RV Iyer J Gibbs B Kuvshinoff, et al. 2007 A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder. A single institution study Ann Surg Oncol 14 3202 3209 10.1245/s10434-007-9539-9 17705089 (Pubitemid 47594289)
27. T Andre C Tournigand O Rosmorduc, et al. 2004 Gemcitabine combined with oxaliplatin in advanced biliary tract adenocarcinoma. A GERCOR study Ann Oncol 15 1339 1343 1:STN:280:DC%2BD2cvhsVektg%3D%3D 10.1093/annonc/mdh351 15319238 (Pubitemid 39295020)
28. F Verderame A Russo R Di Leo, et al. 2006 Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers Ann Oncol 17 suppl 7 68 72
29. SH Park YH Park JN Lee, et al. 2006 Phase II study of epirubicin, cisplatin and capecitabine for advanced biliary tract adenocarcinoma Cancer 106 361 365 1:CAS:528:DC%2BD28XjslOmu7s%3D 10.1002/cncr.21621 16342166 (Pubitemid 43100445)